Global reach Exco InTouch has engaged over 1 million patients across 97 countries and 32,000 hospitals and clinics in 70 languages, highlighting a broad international footprint and experience with multinational trials that can be leveraged to pursue sponsors with global studies.

Pharma trust With 16 of the top 20 pharmaceutical companies deploying Exco InTouch applications, there is strong credibility in data security and regulatory compliance, creating an opportunity to upsell to sponsors seeking reliable patient engagement and compliant data capture solutions.

Integrated platform Exco InTouch combines software and services for digital patient engagement and data capture (eCOA/CRO/Sites) and offers flexible provisioning that integrates into daily life, suggesting cross-selling potential across clinical research, digital health programs, and site management.

Cost containment The platform emphasizes motivated and compliant patients and reduced withdrawal-related costs, presenting a value proposition to sponsors facing trial dropouts and data quality challenges, with potential for expansion into retention analytics and patient support services.

Growth indicators Revenue range indicated at 25 to 50 million and leadership changes noted in CFO roles, signaling potential for selective upsell opportunities with mid-market pharma sponsors and CROs seeking scalable, proven patient engagement solutions.